Ryder M, deLancey-Pulcini E, Parker A, James G
Infect Control Hosp Epidemiol. 2023; 44(11):1760-1768.
PMID: 37088696
PMC: 10665874.
DOI: 10.1017/ice.2023.60.
Gunther F, Blessing B, Tacconelli E, Mutters N
Antimicrob Resist Infect Control. 2017; 6:32.
PMID: 28360994
PMC: 5371339.
DOI: 10.1186/s13756-017-0192-1.
Ramasamy M, Lee J
Biomed Res Int. 2016; 2016:1851242.
PMID: 27872845
PMC: 5107826.
DOI: 10.1155/2016/1851242.
Singh A, Ahmed A, Prasad K, Khanduja S, Singh S, Srivastava J
Antimicrob Agents Chemother. 2015; 59(11):6882-90.
PMID: 26303796
PMC: 4604377.
DOI: 10.1128/AAC.01440-15.
Desrousseaux C, Cueff R, Aumeran C, Garrait G, Mailhot-Jensen B, Traore O
PLoS One. 2015; 10(8):e0135632.
PMID: 26284922
PMC: 4540414.
DOI: 10.1371/journal.pone.0135632.
Microbial biofilms on needleless connectors for central venous catheters: comparison of standard and silver-coated devices collected from patients in an acute care hospital.
Perez E, Williams M, Jacob J, Dent Reyes M, Tejedor S, Steinberg J
J Clin Microbiol. 2013; 52(3):823-31.
PMID: 24371233
PMC: 3957745.
DOI: 10.1128/JCM.02220-13.
Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.
Zhang L, Keogh S, Rickard C
Int J Nanomedicine. 2013; 8:4453-66.
PMID: 24293997
PMC: 3839805.
DOI: 10.2147/IJN.S50312.
In vitro biofilm forming potential of Streptococcus suis isolated from human and swine in China.
Dawei G, Liping W, Chengping L
Braz J Microbiol. 2013; 43(3):993-1004.
PMID: 24031918
PMC: 3768863.
DOI: 10.1590/S1517-838220120003000021.
An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters.
Mazher M, Kallen A, Edwards J, Donlan R
Lett Appl Microbiol. 2013; 57(4):282-7.
PMID: 23710651
PMC: 6467294.
DOI: 10.1111/lam.12108.
Current diagnostic tools for methicillin-resistant Staphylococcus aureus infections.
Kurlenda J, Grinholc M
Mol Diagn Ther. 2010; 14(2):73-80.
PMID: 20359250
DOI: 10.1007/BF03256356.
The Role of msa in Staphylococcus aureus Biofilm Formation.
Sambanthamoorthy K, Schwartz A, Nagarajan V, Elasri M
BMC Microbiol. 2008; 8:221.
PMID: 19087289
PMC: 2648981.
DOI: 10.1186/1471-2180-8-221.
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Weigel L, Donlan R, Shin D, Jensen B, Clark N, McDougal L
Antimicrob Agents Chemother. 2006; 51(1):231-8.
PMID: 17074796
PMC: 1797660.
DOI: 10.1128/AAC.00576-06.
Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time.
Donlan R, Piede J, Heyes C, Sanii L, Murga R, Edmonds P
Appl Environ Microbiol. 2004; 70(8):4980-8.
PMID: 15294838
PMC: 492445.
DOI: 10.1128/AEM.70.8.4980-4988.2004.
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
cernohorska L, Votava M
Folia Microbiol (Praha). 2004; 49(1):75-8.
PMID: 15114870
DOI: 10.1007/BF02931650.
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu J, Kusuma C, Mond J, Kokai-Kun J
Antimicrob Agents Chemother. 2003; 47(11):3407-14.
PMID: 14576095
PMC: 253758.
DOI: 10.1128/AAC.47.11.3407-3414.2003.
Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms.
Purevdorj B, Costerton J, Stoodley P
Appl Environ Microbiol. 2002; 68(9):4457-64.
PMID: 12200300
PMC: 124093.
DOI: 10.1128/AEM.68.9.4457-4464.2002.
Biofilms: survival mechanisms of clinically relevant microorganisms.
Donlan R, Costerton J
Clin Microbiol Rev. 2002; 15(2):167-93.
PMID: 11932229
PMC: 118068.
DOI: 10.1128/CMR.15.2.167-193.2002.
Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model.
Murga R, Miller J, Donlan R
J Clin Microbiol. 2001; 39(6):2294-7.
PMID: 11376074
PMC: 88128.
DOI: 10.1128/JCM.39.6.2294-2297.2001.